and 25 patients received a combination of acetyl-l-carnitine at a dose used in arm A plus low-dose, i.e., 150 mg/day, pregabalin (arm C) for 8 weeks and were subsequently observed for an additional 8 weeks to assess relapse latency and frequency
Analyst 1.6.0 software (AB Sciex) was applied to control system, align spectrum, and gather amino acid and carnitine/acylcarnitine data
Korner: GLP-1 agonists (commonly referred to as GLP-1s), such as Ozempic and Wegovy, are a class of medications originally designed for diabetic and medically overweight patients
This can set off a vasovagal response, marked by lightheadedness, pale skin, and nausea
Presented here, the numbers are a documented reference protocol under research-use-only framing not a claim about what any individual will experience